TL;DR
This paper reports an extremely rare case of a left atrial myxoma that rapidly expanded due to acute internal hemorrhages. This finding challenges the common perception of myxomas as slow-growing tumors and highlights the critical need to consider the potential for rapid, life-threatening deterioration due to internal bleeding.
What Problem Does This Paper Address?
Cardiac myxomas, particularly left atrial myxomas, are the most common primary heart tumors. While generally considered benign and slow-growing, they can cause serious complications like arterial embolism, obstruction of blood flow, and sudden death. This necessitates early surgical intervention. However, the exact growth rate and the factors influencing rapid expansion have not been fully elucidated. This paper addresses the gap in understanding how myxomas can undergo rapid, acute enlargement, presenting a case that dramatically challenges the "slow-growing" paradigm.
Methods
The study is primarily a case report with a literature review. The key methods involved:
- Echocardiography: Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) were used to visualize the tumor, assess its size, morphology, and changes over time. This is a standard diagnostic tool for cardiac tumors.
- Surgical Resection: The myxoma was surgically removed using standard cardiopulmonary bypass and cardioplegic arrest techniques.
- Pathological Examination: The resected tumor was examined histologically to determine its nature and identify any underlying pathological processes, such as hemorrhage.
- Literature Review: The authors conducted a review of existing English literature to gather data on reported growth rates of left atrial myxomas and to contextualize their findings.
The novelty lies not in the techniques themselves, which are standard, but in the application to a highly unusual presentation of a myxoma.
Datasets
Not discussed in the paper. The study relies on a single patient's clinical data and a review of published case reports.
Key Insights and Ideas
- Myxomas can expand rapidly due to internal hemorrhage: The most striking insight is that acute, massive internal bleeding within a myxoma can cause dramatic and rapid increases in tumor size, leading to acute symptomatic deterioration. This challenges the long-held notion of myxomas as exclusively slow-growing.
- Internal hemorrhage alters tumor morphology and fragility: The presence of multiple hematomas significantly changed the tumor's size, shape, and likely its structural integrity, making it more fragile.
- "Slow-growing" tumors can have acute, life-threatening events: This case serves as a critical reminder that even tumors perceived as slow-growing can undergo sudden, dangerous changes, emphasizing the importance of vigilance and prompt intervention.
- Potential link to SARS-CoV-2 vaccination: The patient experienced symptoms four weeks after her fifth SARS-CoV-2 vaccination, and while a direct causal link cannot be confirmed, the authors suggest this warrants further attention for possible intratumor hemorrhage after vaccination.
Key Results
- A 64-year-old woman presented with a left atrial myxoma that rapidly expanded from approximately 25x35 mm to 40x50 mm within a few hours.
- This rapid expansion was attributed to acute multiple internal hemorrhages within the tumor, which were visualized as cystic lesions on echocardiography.
- The patient experienced sudden dyspnea and decreased oxygen saturation due to the tumor's obstruction of blood flow.
- Emergency surgery was performed, and the resected tumor measured 50x38 mm and showed evidence of massive fresh central hemorrhage and lobular subcapsular bleeding.
- Histological examination revealed spindle-shaped cells, hyperchromatic nuclei, myxomatous stroma, hemosiderin pigmentation, and erythrocytes, indicating both chronic and fresh bleeding.
- The patient recovered uneventfully after surgical resection.
- A literature review indicated a median growth rate of 3.5 mm/month for LA myxomas, with a wide range, but no prior reports of multiple cystic lesions due to intratumor hemorrhage.
Limitations and Future Work
- Single Case Report: The findings are based on a single patient, limiting the generalizability of the observations.
- Unclear Cause of Hemorrhage: The exact cause of the internal hemorrhage remains unknown, despite ruling out trauma, bleeding tendencies, and coagulation disorders.
- Potential Vaccination Link: While the authors mention a possible correlation with SARS-CoV-2 vaccination, this is speculative and requires further investigation.
Future work could involve:
- Prospective studies to better understand the incidence and mechanisms of intratumor hemorrhage in myxomas.
- Further investigation into potential triggers for hemorrhage, including vaccinations or other inflammatory processes.
- Developing strategies to identify myxomas at higher risk for rapid expansion due to hemorrhage.
Summary updated